From Emily Singer's article yesterday in Technology Review:
(This paragraph has also been picked up by Slashdot, and pointed to by wyattsgirl.)
What sort of tests are Amway selling? Here's the low-down:
(From here.) Here's a hint for potential customers: one marker in one gene is not a useful predictor for heart disease risk, and any test that speaks vaguely about "identifying differences" without specifying what those differences are should be treated with extreme caution.
(Added in edit: In the comments, Interleukin Genetics' Erin Walsh disputes my claim that the test literature "speaks vaguely" about the variants tested; but while it is indeed possible to find more information on the Interleukin Genetics website, it's difficult or impossible to get this information from the Amway site selling their tests. See my comment below for responses to other points raised by Walsh.)
I found these adjacent segments from the FAQ amusing:
I guess they want to steer well clear of that classic danger sign, advertising supplements tailored to specific genetic test results (note: __any __company that tries to do this is scamming you, pure and simple), so they've gone to great lengths to separate the test results from the supplement recommendations while encouraging customers to move directly from one to the other.
These are the types of tests that give direct-to-consumer genetic testing a bad name; careful regulation that punishes these bottom-feeders while leaving scientifically supported tests intact (i.e. the major personal genomics companies) is long overdue.